Global Side Menu Width Placeholder

Publications

Associate Professor (Hon.) Richard Martin is New Zealand’s leading Melanoma Surgical Oncologist specialising in melanoma, neck lumps, endocrine surgery and more. After spending two and a half years at the Sydney Cancer Centre, he completed a Master of Surgery in Surgical Oncology and the University of Sydney. 

Richard shares his knowledge by contributing to numerous academic journals. He presents at national and international conferences, actively contributes to research and clinical trials as an Associate Professor at the University of Auckland. Please see Richard’s CV and publication list.

Learn more about his areas of expertise in the publications below. 

  1. A randomised controlled multicentre trial of imiquimod versus radiotherapy for lentigo maligna. A. Hong, S Lo, G Fogarty, J Stretch, T Wang, P Fernandez-Penas, R Martin, M Foote, Peter Soyer, J Ruben, V Mar, L Rocha, C Wratten, H Collgros, A Pereira, B Gouvea, R Scolyer, M King, P Guitera. Submitted to JAAD
  2. Predicting sentinel node positivity in patients with primary cutaneous melanoma: an international study validating the MIA risk calculator and increasing precision. Serigne N. Lo, Caroline Gjorup, Annette Hougaard Chakera, Lisbet Rosenkrantz Hölmich, Marc Moncrieff, Alastair MacKenzie Ross, Oliver Cassell, Jiawen Ma, Marie Brinch-Møller Weitemeyer, Roger Olofsson Bagge, Siri Klausen, Vinicius F. Calsavara, João P. Duprat Neto, Eduardo Bertolli, Sydney Ch’ng, Robyn P. M. Saw, Kerwin F. Shannon, Andrew J. Spillane, Omgo E. Nieweg, MD, Jonathan R. Stretch, DPhil; Graham J. Mann, Jenny L. C. Geh, Lauren E. Haydu, Richard C. W. Martin, Cimarron Sharon, Giorgos C. Karakousis, Mohammed Kashani-Sabet, George Adigbli, Mary-Ann El Sharouni, Jeffrey E. Gershenwald, Richard A. Scolyer, John F. Thompson, Alexander H. R. Varey. JAMA Dermatology. Published online April 9, 2025. Doi:10.1001/jamadermatol.2025.0318
  3. Exploring melanoma shifts: a two decade analysis in New Zealand. Daniel Wen, Jack S Pullman, Avinash Sharma, Bert van der Werf, Richard C W Martin. NZMJ 2024 Jun 7; 137(1596)
  4. Proliferating CD163+ macrophages in human tumours have characteristics of monocytes responding to myelopoietic growth factors. Saem Mul Park, Chun-Jen J. Chen, Daniel J. Verdon, Marcus P. Y. Ooi, Anna E. S. Brooks, Richard C. W. Martin, on A. Mathy, Patrick O. Emanuel, P. Rod Dunbar. https://doi.org/10.3389/fimmu.2024.1412076 Frontiers in Immunology, section Cancer Immunity and Immunotherapy, Volume 15. June 2024.
  5. A rare case of basomelanocytic tumour. D Wen, T Chen, RCW Martin. American Journal of Dermatopathology 2023; 45(8): 64-66
  6. Seven-Colour Multiplex Immunochemistry/Immunofluorescence and Whole Slide Imaging of Frozen Sections.  Submitted to The Journal of Pathology: Clinical Research. S Park, C Chen, J Mathy, S Lin, R Martin, J Mathy, R Dunbar. Journal of Immunological Methods 2023; 10; 518:113490. DOI: 10.1016/j.jim.2023.113490
  7. Evolving genomic complexity in melanoma is detected by orthogonal ctDNA analysis technologies in immunotherapy-treated patients. S Fitzgerald, C Print, RCW Martin et al. Molecular Diagnosis and Therapy. April 2023. DOI:10.1007/s40291-023-00651-4
  8. Surgical Management of Graves’ disease: Historical context and single institution experience. M Russell, R Martin, R Harman. NZMJ 2022; 135(1549):43-49
  9. Virtual Lesion Clinic-evaluation of a teledermatology triage system for referrals for suspected melanoma. Rebecca Teague, Mark Wang, Daniel Wen, Michael Sunderland B, Gill Rolfe, Amanda M Oakley, Marius Rademaker, Richard Martin. Australasian Journal of Dermatology 2022: 63(1); e33-40
  10. Proposed Quality Performance Indicators (QPI’s) for axillary lymphadenectomy in metastatic cutaneous melanoma. Ollek S, Wen D, Ong I, Anderson W, Harman R, Martin R Eur J Surg Oncol. 2021 doi:10.1016/j.ejso.2021.07.030. Epub ahead of print. PMID: 34489121.
  11. Morbidity following thyroid and parathyroid surgery: Results from key performance indicator assessment at a high-volume centre in New Zealand. Lin JX, Wen D, Sharma A, van der Werf B, Martin RCW, Harman R. ANZ J Surg. 2021; Sep;91(9):1804-1812. doi: 10.1111/ans.17099. Epub 2021 Aug 17. PMID: 34405501.
  12. Contemporary management of locoregionally advanced melanoma in Australia and New Zealand and the role of adjuvant systemic therapy. B Mark Smithers, Robyn PM Saw, David E Gyorki, Richard CW Martin, Victoria Atkinson, Andrew Haydon, Rachel Roberts-Thomson, John F Thompson. ANZJS 2021; 91(2): 3-13
  13. Proposed quality performance indicators of sentinel lymph node biopsy for cutaneous melanoma. ANZ J Surg. 2021 Wen D, Martin RCW. doi:10.1111/ans.16914. Epub ahead of print. PMID: 33956390.
  14. A case of cystic lymphatic malformation mimicking acute appendicitis in an adult patient: a rare diagnostic pitfall. M Joret, A Nananyakkra, RCW Martin. BMJ Case Rep 2021; 14:e239509
  15. Radiological imaging of melanoma: a review to guide clinical practice in New Zealand. Francis V, Sehji T, Barnett M, Martin RCW. NZ Med J. 2021 Jan 15;134(1528):79-87. PMID: 33444308.
  16. Distinctive populations of human lymph node stromal cells contribute to cancer-associated fibroblasts following melanoma metastasis (Running title: Stromal cells in Melanoma-infiltrated lymph nodes). Jennifer Eom, Saem Mul Park, Vaughan Feisst, Chun-Jen J. Chen, Julie D. McIntosh, Catherine E. Angel, Adam Bartlett, Richard Martin, Jonathan Cebon, Michael A Black, Anna E.S. Brooks, P. Rod Dunbar. Cancer Immunology Research 2020; 8(8): 990-1003
  17. Quality Measures in Cervical Lymphadenectomy for cutaneous malignancy by Head and Neck trained General Surgeons. F Nahab, Sita Olek, RCW Martin. NZMJ 2020; 1 33(1520); 50-60
  18. E-referrals and teledermatoscopy grading for melanoma: a successful model of care. Sunderland M, Teague R, Gale K, Rademaker M, Oakley A, Martin RCW. Australas J Dermatol. 2020 May;61(2):147-151. doi: 10.1111/ajd.13230. Epub 2020 Feb 16. PMID: 32064590.
  19. Quality assessment of a large primary GP skin cancer service in Auckland, New Zealand. Wen D, Gale K, Martin R. N Z Med J. 2020 Feb 7;133(1509):17-27. PMID:32027635.
  20. Sentinel Node Biopsy in 105 high risk cutaneous SCC of the Head and Neck: Results of  a multicentre trial. Craig P. Mooney, Richard C. W. Martin, Richard Dirven, Bruce G. Ashford, Kerwin Shannon, Carsten E. Palme, Quan Ngo, James Wykes, Sarah Davies, Kan Gao, Sydney Ch’ng, Tsu-Hui (Hubert) Low, Ruta Gupta, Jonathan R. Clark. Ann Surg Oncol 2019 Dec; 26(13):4481-4488.
  21. Body site distribution of squamous cell and basal cell cancer in a high-risk New Zealand population. Essa Tawfiq, Mark Elwood, G Rolfe, P Emanual, Richard Martin. Journal of Experimental Dermatology 2019; 6(2): 030
  22. WOUND Study: a cost-utility analysis of negative pressure wound therapy following split skin grafting for lower limb skin cancer. Helen J Ker, Abbas Al-Murrani, Gill Rolfe, Richard CW Martin. Journal of Surgical Research 2019; 253: 308-314
  23. Elective Services Productivity and Effectiveness Review: Waitemata DHB Skin Clinic and Procedure Model of Care. M Broome, K Macfarlane, RCW Martin. February 2018 EPUB.
  24. WOUND trial. A prospective randomised trial of bolster dressing v’s negative pressure suction dressing and early mobilisation for lower limb skin grafts. R Vather, H Hammodat, K Gale, RCW Martin. JPRAS 2018; 71(7): 1100-1102
  25. The burden of non-melanoma skin cancer in Auckland, NZ. A Podicherry, P Emanual, I  Meredith, RCW Martin, M Elwood. Australasian Journal of Dermatology 2018; 59 (3): 210-213
  26. Epidemiology of Melanoma in Situ in New Zealand. Sam Rice, Richard Martin. NZMJ  2018; 131(1482): 73-79
  27. Establishment of a national “complex” BCC database. M Carpenter, RCW Martin. RCW  Martin, M Carpenter, G Rolfe, R Carpenter. Clinical Skin. Cancer 2016; 1(2): 82-87
  28. Prospective study of sentinel node biopsy for high-risk cutaneous squamous cell carcinoma of the head and neck. Sinclair M. Gore, Douglas Shaw, Richard C.W. Martin, Kathryn Roth, Roger Uren, Kan Gao, Sarah Davies, Bruce G. Ashford, Quan Ngo, Kerwin Shannon and Jonathan R. Clark. Head & Neck April 2016; 38: 884–889
  29. Successful melanoma triage by virtual lesion clinic (teledermatology). Congalton AT, Oakley AM, Rademaker M, Bramley D, Martin RCW. JEADV 2015 Dec; 29(12): 2423-8
  30. Predicting lymph node metastases in cutaneous squamous cell carcinoma: use of a morphological scoring system.  Nicholas J M Agar, Christopher Kirton, Rajan Patel, Richard C W Martin, Neville Angelo, Patrick O Emanuel. NZMJ 2015; 128(1411)
  31. Epidemiology of Merkel Cell Carcinoma in New Zealand: A population-based study. Robertson JP, Liang ES, Martin RC. B J of Dermatology 2015; 173(3):835–837
  32. Standards of Service Provision for Melanoma Patients in New Zealand. RCW Martin, Chairman of Melanoma group published 2013.
  33. Combined cellular blue naevus and trichoepithelioma. Martin RC, Emanuel PO. J Clin  Aesthet Dermatol. 2013 Aug; 6(8):35-8.
  34. The Management of Cervical Nodes in Cutaneous Melanoma. RCW Martin, K Gao, K  Shannon, A Spillane, J Stretch, CJ O’Brien, JF Thompson. Ann Surg Oncol 2012 Nov; 19(12): 3926-32.
  35. Malignant Melanoma amongst Maori and New Zealand Europeans, 2000-2004.T Hore, E  Robinson, RCW Martin. WJS 2010; 34(8): 178801792
  36. Cutaneous Melanoma in New Zealand: 2000-2004. Jennifer JC Liang, Elizabeth Robinson, Richard CW Martin. ANZJS 2010; 80(5): 321-316.
  37. So-called “malignant blue naevus” – a clinico-pathological study of 23 cases. Richard C. W. Martin, Rajmohan Murali, Richard A. Scolyer, Patrick, Fitzgerald, Margaret H.  Coleman and John F. Thompson. Cancer 2009; 115(13): 2949-2955.
  38. Efficacy of repeat Positron Emission Tomography (PET) in the evaluation of patients treated with chemoradiotherapy for mucosal head and neck cancer. RCW Martin, M Fulham, CJ O’Brien et al. Head Neck. 2009; 31(2): 244-50.
  39. Adjuvant Postoperative Radiotherapy to Cervical Lymph Nodes in Cutaneous Melanoma:  Is there Any Benefit for High Risk Patients? Marc D Montcrief, Richard Martin,  Christopher J. O’Brien, Kerwin F Shannon, Jonathon R Clark, Kan Gao, William M McCarthy and John F Thompson. Annals of Surgical Oncology 2008; 15(11): 3022-3027.
  40. Uteroplacental ischemia results in proteinuric hypertension and elevated sFLT-1. A Makris, C Thornton, S Thompson, J Thompson, R Martin, P Mckenzie, R Ogle, R Waugh, A Hennessy. Kidney International 2007; 71(10): 977-84.
  41. The role of Sentinel Node Biopsy in high-risk Cutaneous Squamous Cell Carcinoma. R  Martin. Master’s thesis, University of Sydney, 2007
  42. Ossified adrenocortical adenoma: an unusual radiological and morphological appearance.  EDM Fong, R Martin, IM Cranshaw, A Morrine, JHF Shaw. ANZJS 2005; 75(9): 835
  43. Necrotising Fasciitis in South Auckland. A Tiu, RCW Martin, A MacCormick, A Hill. ANZJS 2005; 75(1-2): 32-4
  44. Allergic reactions to enoxaparin and heparin: a case report and review of the literature. Albert Tiu, Jia-Min Pang, Richard Martin, Neil Officer. NZMJ 2004; 117-120
  45. Cutaneous Melanoma in Caucasian New Zealanders. RCW Martin, E Robinson. ANZJS  2004; 74: 233-7
  46. Sentinel node biopsy in breast cancer: validation study and comparison of blue dye alone with triple modality localization. RCW Martin, W Myer-Rochow, CR Harman. ANZJS 2003; 73(10):815-818

BOOK CHAPTERS
  1. Non-melanoma skin cancer. RCW Martin, W Cooper, CS Lee, CJ O’Brien. Head and Neck Surgery and Oncology: Principles and Practice. 2006 BC Decker online textbook. www.bcdecker.com
  2. Stell and Maran’s Text Book of Head and Neck Surgery and Oncology, 5th Edition, 2012. Hodder and Arnold. Chapter 36. Non melanoma and melanoma skin cancer. RCW Martin, J Clark.
  3. Treating advanced Basal Cell Carcinoma in NZ. Research review educational series, 2014. www.researchreview.co.nz
  4. Quality Statements to Guide Melanoma Care in New Zealand. RCW Martin, lead author and chairman of the New Zealand Melanoma Working Group (Cancer Control Agency). First edition published online 2022, Melnet website

1. Proposed Quality Performance indicators (QPI’s) for axillary lymphadenectomy in Melanoma. Accepted for publication in EJSO, July 2021

2. Morbidity following thyroid and parathyroid surgery: Results from key performance indicator assessment at a high-volume centre in New Zealand. ANZJS 2021; 91: 1804-1812

3. Contemporary management of  locoregionally advanced melanoma in Australia and New Zealand and the role of adjuvant systemic therapy. B Mark Smithers, Robyn PM Saw, David E Gyorki, Richard CW Martin,Victoria Atkinson, Andrew Haydon, Rachel Roberts-Thomson, John F Thompson. ANZJS 2021; 91(2): 3-13

4. Proposed quality performance indicators of sentinel lymph node biopsy for cutaneous Melanoma. ANZJS 2021. Epub ahead of print. PMID: 33956390.

5. A case of cystic lymphatic malformation mimicking acute appendicitis in an adult patient: a rare diagnostic pitfall. M Joret, A Nananyakkra, RCW Martin. BMJ Case Rep 021; 14:e239509

6.Radiological Imaging of Melanoma: A Review to guide clinical practice in New Zealand. NZMJ 2021; 134(1528): 79-87

7. Distinctive populations of human lymph node stromal cells contribute to cancer-associated fibroblasts following melanoma metastasis (Running title: Stromal cells in Melanoma-infiltrated lymph nodes). Jennifer Eom, Saem Mul Park, Vaughan Feisst, Chun-Jen J. Chen, Julie D. McIntosh, Catherine E. Angel, Adam Bartlett, Richard Martin, Jonathan Cebon, Michael A Black, Anna E.S. Brooks, P. Rod Dunbar. Cancer Immunology Research 2020; 8(8): 990-1003

8. Quality Measures in Cervical Lymphadenectomy for cutaneous malignancy by Head and Neck trained General Surgeons. F Nahab, Sita Olek, RCW Martin. NZMJ 2020; 133(1520); 50-60

9. E-referrals and teledermatoscopy grading for melanoma, a successful model of care. AJD 2020 May; 61(2): 147-151

10. Quality assessment of a large primary skin cancer service in Auckland, New Zealand. NZMJ 2020; 133(1509):17-27

11. Sentinel Node Biopsy in 105 high risk cutaneous SCC of the Head and Neck: Results of a multicentre trial. Craig P. Mooney, Richard C. W. Martin, Richard Dirven, Bruce G. Ashford, Kerwin Shannon, Carsten E. Palme, Quan Ngo, James Wykes, Sarah Davies, Kan Gao, Sydney Ch’ng, Tsu-Hui (Hubert) Low, Ruta Gupta, Jonathan R. Clark. Ann Surg Oncol 2019 Dec; 26(13):4481-4488.

12. Body site distribution of squamous cell and basal cell cancer in a high risk New Zealand population. Essa Tawfiq, Mark Elwood, G Rolfe, P Emanual, Richard Martin. Journal of Experimental Dermatology 2019; 6(2): 030

13. WOUND Study: a cost-utility analysis of negative pressure wound therapy following split-skin grafting for lower limb skin cancer. Helen J Ker, Abbas Al-Murrani, Gill Rolfe, Richard CW Martin. Journal of Surgical Research 2019; 253: 308-314

14. Elective Services Productivity and Effectiveness Review: Waitemata DHB Skin Clinic and Procedure Model of Care. February 2018 EPUB. M Broome, K Macfarlane, RCW Martin

15. WOUND trial. A prospective randomised trial of bolster dressing v’s negative pressure suction dressing and early mobilisation for lower limb skin grafts. R Vather, H Hammodat, K Gale, RCW Martin. JPRAS 2018; 71(7): 1100-1102

16. The burden of non-melanoma skin cancer in Auckland, NZ. A Podicherry, P Emanual, I Meredith,  RCW Martin, M Elwood. Australasian Journal of Dermatology 2018; 59 (3): 210-213

17. Epidemiology of Melanoma in Situ in New Zealand. Sam Rice, Richard Martin. NZMJ 2018; 131(1482): 73-79

18. Establishment of a national “complex” BCC database. M Carpenter, RCW Martin. RCW Martin, M Carpenter, G Rolfe, R Carpenter. Clinical Skin. Cancer 2016; 1(2): 82-87

19. Prospective study of sentinel node biopsy for high risk cutaneous squamous cell carcinoma of the head and neck. Sinclair M. Gore, Douglas Shaw, Richard C.W. Martin, Kathryn Roth, Roger Uren, Kan Gao, Sarah Davies, Bruce G. Ashford, Quan Ngo, Kerwin Shannon and Jonathan R. Clark. Head & Neck April 2016; 38: 884–889

20. Successful melanoma triage by virtual lesion clinic (teledermatology). Congalton AT, Oakley AM, Rademaker M, Bramley D, Martin RCW. JEADV 2015 Dec; 29(12): 2423-8

21. Predicting lymph node metastases in cutaneous squamous cell carcinoma: use of a morphological scoring system.  Nicholas J M Agar, Christopher Kirton, Rajan Patel, Richard C W Martin, Neville Angelo, Patrick O Emanuel. NZMJ 2015; 128(1411)

22. Epidemiology of Merkel Cell Carcinoma in New Zealand: A population based study. Robertson JP, Liang ES, Martin RC. B J of Dermatology 2015; 173(3):835–837

23. Standards of Service Provision for Melanoma Patients in New Zealand. RCW Martin, Chairman of Melanoma group, published 2013.

24. Combined cellular blue naevus and trichoepithelioma. Martin RC, Emanuel PO. J Clin Aesthet Dermatol. 2013 Aug; 6(8):35-8.

25. The Management of Cervical Nodes in Cutaneous Melanoma. RCW Martin, K Gao, K Shannon, A Spillane, J Stretch, CJ O’Brien, JF Thompson. Ann Surg Oncol 2012 Nov; 19(12): 3926-32.

26. Malignant Melanoma amongst Maori and New Zealand Europeans, 2000-2004.T Hore, E Robinson, RCW Martin. WJS 2010; 34(8): 178801792

27. Cutaneous Melanoma in New Zealand: 2000-2004. Jennifer JC Liang, Elizabeth Robinson and Richard CW Martin. ANZJS 2010; 80(5): 321-316.

28. So-called “malignant blue naevus” – a clinico-pathological study of 23 cases. Richard C. W. Martin, Rajmohan Murali, Richard A. Scolyer, Patrick, Fitzgerald, Margaret H. Coleman and John F. Thompson. Cancer 2009; 115(13): 2949-2955.

29. Efficacy of repeat Positron Emission Tomography (PET) in the evaluation of patients treated with chemoradiotherapy for mucosal head and neck cancer. RCW Martin, M Fulham, CJ O’Brien et al. Head Neck. 2009; 31(2): 244-50.

30. Adjuvant Postoperative Radiotherapy to Cervical Lymph Nodes in Cutaneous Melanoma: Is there Any Benefit for High Risk Patients? Marc D Montcrief, Richard Martin, Christopher J. O’Brien, Kerwin F Shannon, Jonathon R Clark, Kan Gao, William M McCarthy and John F Thompson. Annals of Surgical Oncology 2008; 15(11): 3022-3027.

31. Uteroplacental ischemia results in proteinuric hypertension and elevated sFLT-1. A Makris, C Thornton, S Thompson, J Thompson, R Martin, P Mckenzie, R Ogle, R Waugh, A Hennessy. Kidney International 2007; 71(10): 977-84.

32. The role of Sentinel Node Biopsy in high risk Cutaneous Squamous Cell Carcinoma. R Martin. Master’s thesis, University of Sydney, 2007

33. Ossified adrenocortical adenoma: an unusual radiological and morphological appearance. EDM Fong, R Martin, IM Cranshaw, A Morrine, JHF Shaw. ANZJS 2005; 75(9): 835

34. Necrotising Fasciitis in South Auckland. A Tiu, RCW Martin, A MacCormick, A Hill. ANZJS 2005; 75(1-2): 32-4

35. Allergic reactions to enoxaparin and heparin: a case report and review of the literature. Albert Tiu, Jia-Min Pang, Richard Martin, Neil Officer. NZMJ 2004; 117-120

36. Cutaneous Melanoma in Caucasian New Zealanders. RCW Martin, E Robinson. ANZJS 2004; 74: 233-7

37. Sentinel node biopsy in breast cancer: validation study and comparison of blue dye alonewith triple modality localization. RCW Martin, W Myer-Rochow, CR Harman. ANZJS 2003; 73(10):815-818

BOOK CHAPTERS

1. Non-melanoma skin cancer. RCW Martin, W Cooper, CS Lee, CJ O’Brien. Head and Neck Surgery and Oncology: Principles and Practice. 2006 BC Decker online textbook. www.bcdecker.com

2. Stell and Maran’s Text Book of Head and Neck Surgery and Oncology, 5th Edition, 2012. Hodder and Arnold. Chapter 36. Non melanoma and melanoma skin cancer. RCW Martin, J Clark.

3. Treating advanced Basal Cell Carcinoma in NZ. Research review educational series, 2014. www.researchreview.co.nz